论文信息 - Randomized, multicenter phase III study of ranpirnase plus doxorubicin (DOX) versus DOX in patients with unresectable malignant mesothelioma (MM). - 字舞流文

Randomized, multicenter phase III study of ranpirnase plus doxorubicin (DOX) versus DOX in patients with unresectable malignant mesothelioma (MM).

M. Krzakowski | J. Jassem | J. von Pawel | U. Gatzemeier | J. Kozielski | M. Reck | K. Shogen | J. Costanzi | J. Pawel | C. Eschbach | Jacek Jassem | M. Krzakowski | Jerzy Kozielski